KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortization - Intangibles: 2017-2024

Historic Amortization - Intangibles for Adaptive Biotechnologies (ADPT) over the last 8 years, with Dec 2024 value amounting to $1.7 million.

  • Adaptive Biotechnologies' Amortization - Intangibles changed negligibly% to $428,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 0.35%. This contributed to the annual value of $1.7 million for FY2024, which is 0.24% up from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Amortization - Intangibles of $1.7 million as of FY2024, which was up 0.24% from $1.7 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Amortization - Intangibles registered a high of $1.7 million during FY2020, and its lowest value of $1.7 million during FY2021.
  • Moreover, its 3-year median value for Amortization - Intangibles was $1.7 million (2023), whereas its average is $1.7 million.
  • In the last 5 years, Adaptive Biotechnologies' Amortization - Intangibles grew by 0.29% in 2020 and then declined by 0.23% in 2021.
  • Over the past 5 years, Adaptive Biotechnologies' Amortization - Intangibles (Yearly) stood at $1.7 million in 2020, then declined by 0.23% to $1.7 million in 2021, then remained steady at $1.7 million in 2022, then remained steady at $1.7 million in 2023, then increased by 0.24% to $1.7 million in 2024.